How Much Weight Can You Lose on Semaglutide? Real Numbers

Most patients lose about 15 percent of their body weight on semaglutide at the full 2.4 mg maintenance dose. That’s roughly 30 pounds for someone starting at 200 pounds, measured over about 68 weeks. Adults with type 2 diabetes average closer to 10 percent. Your dose, your starting weight, and your daily habits move that number in both directions.

How Much Weight Can You Lose on Semaglutide?

Here are the real trial numbers, not marketing ones. In the STEP 1 trial, published in the New England Journal of Medicine, adults taking semaglutide 2.4 mg lost 14.9 percent of their body weight across 68 weeks. Patients on placebo lost 2.4 percent. Both groups received the same nutrition and physical activity coaching, so the gap came from the drug.

About half of those patients lost 15 percent or more. Roughly one in three crossed 20 percent. Since patients started around 232 pounds on average, average weight loss landed near 34 pounds.

That spread matters more than the headline. Some patients finish well above it, and some finish below. In our experience, the ones who land near the trial average are the ones who reach the full dose and hold it, while the ones who finish under it usually stalled somewhere in the ramp. So we set weight loss goals from your labs and your history rather than from a number you read online.

What Do the STEP Trials Show by Group?

Semaglutide has been studied in a run of trials named STEP, short for Semaglutide Treatment Effect in People with obesity. Each one tested semaglutide treatment against placebo, with lifestyle changes on both sides.

Two patterns jump out of that table. A higher dose does more than a smaller one, though not double. And type 2 diabetes changes the math.

Why Does Type 2 Diabetes Change the Result?

Semaglutide began as a diabetes drug. The U.S. Food and Drug Administration approved it for type 2 diabetes in 2017 as Ozempic, then for chronic weight management in 2021 as Wegovy. Same molecule, different dose and different label.

Patients with type 2 diabetes still see real weight loss, just less on average. The reasons aren’t fully settled. Insulin and older diabetes medication can push weight up on their own. High blood sugar spills calories into urine, so correcting blood sugar levels can quietly reclaim calories your body was throwing away. Years of diabetes may also change how fat tissue responds.

The blood sugar side deserves its own line. Semaglutide prompts your pancreas to release insulin when glucose runs high, and it slows how fast your stomach empties. A patient with type 2 diabetes usually watches A1c fall alongside the scale. Without diabetes, steadier blood sugar shows up as fewer afternoon crashes and less evening snacking.

How Fast Does the Weight Come Off?

Slowly, and that’s deliberate. Appetite usually fades before the scale moves. Semaglutide dosing starts low and steps up every four weeks. That ramp isn’t caution for its own sake. It’s how you avoid the gastrointestinal side effects that make patients quit in month one.

That schedule comes from the approved label. Your provider can hold you at a lower dose for longer when side effects flare, or park you at 1.7 mg if you’re losing well there. A higher dose isn’t automatically a better dose for you.

Our patients feel the appetite change before the scale reflects it, and that gap makes people nervous. We saw it often enough that we now name it at the ramp visit: a quiet appetite in weeks one and two is the medication doing its job, even while the scale sits still.

What Does 15 Percent Look Like in Pounds?

Percentages hide how different two results feel. Here is the same trial average translated into pounds by starting body weight.

Notice where the health benefit starts. According to the National Institute of Diabetes and Digestive and Kidney Diseases, losing 5 to 10 percent of your initial body weight already improves blood pressure, blood sugar, and cholesterol. Significant weight loss in the medical sense begins lower than most patients expect.

Why Do Some Patients Lose More Than Others?

Averages flatten a wide range of real weight loss results. A few things explain the spread.

• Your starting weight. Patients who begin heavier tend to drop more pounds at the same percentage.
• Your dose and how long you hold it. Reaching and holding the full 2.4 mg dose is where the bulk of loss happens.
• Food and physical activity. The medication lowers appetite; what you eat during that window still decides the result.
• Sleep and stress. Short sleep raises appetite hormones and works against you.
• Other prescriptions. Certain medication for mood, blood sugar, or blood pressure nudges weight upward.
• Your biology. Bodies respond differently to the same medication, and that’s normal.

One patient holds at 1.7 mg and keeps losing steadily. Another needs the full 2.4 mg before much moves at all. Neither is doing something wrong, and the plan should follow your response rather than the label.

Injection, Pill, or Compounded: Does the Form Matter?

This medication comes in more than one form, and patients ask about all three.

The injection. A weekly semaglutide injection is what the STEP trials tested. Semaglutide injections remain the version with the deepest evidence behind them for weight management.

The pill. Oral semaglutide, sold as Rybelsus, is FDA approved for type 2 diabetes at 7 mg and 14 mg. A semaglutide pill at those doses isn’t labeled as a weight loss medication. Much higher oral doses have been studied for weight loss, with averages close to the injection. Ask your provider what’s approved and stocked right now, because this area keeps moving.

Compounded semaglutide. A compounded medication is mixed by a licensed pharmacy instead of made by the manufacturer. Compounded semaglutide isn’t FDA approved, and the FDA has warned about dosing errors and about products built on salt forms that aren’t the same active ingredient. It can still be a reasonable supervised option in certain situations. We tell you honestly whether that specific medication fits your case, and we only work with pharmacies we can vouch for.

What Happens to Your Weight If You Stop?

Weight regain is the honest risk, and the trials measured it directly. In STEP 4, patients climbed to the 2.4 mg dose over 20 weeks. Half continued, and half switched to placebo. The group that stayed on semaglutide lost about 8 percent more. The group that stopped gained back close to 7 percent.

A follow-up on STEP 1 patients found something similar. One year after stopping, they had regained roughly two thirds of what they lost.

Read that as biology, not as failure. The medication works while it’s in your system, and appetite returns when it leaves. Obesity behaves like a chronic condition. That’s exactly why the FDA label says chronic weight management rather than a 12 week course.

How Do You Protect Your Weight Loss Long Term?

This is the part that decides your weight loss outcomes three years from now, and most of it is not the drug.

• Protein at every meal. Protein protects muscle while your calorie intake drops.
• Strength training twice a week. Muscle is what keeps your metabolic health steady during a long weight loss journey.
• Physical activity you will repeat. Walking counts. The plan that works is the one still happening in March.
• Regular labs. We track A1c, lipids, thyroid, and kidney markers rather than guessing.
• A maintenance plan built early. Some patients stay on the medication at a lower dose long term. Others taper with a written food and physical activity plan.

We learned to put the maintenance conversation in the first visit rather than in month nine. A taper you planned for is a different experience from a taper you improvise after the scale stops moving.

According to the NIDDK, weight management medication works best alongside lifestyle changes rather than instead of them. No medication does the job alone. That’s the whole model here. Steady losing weight, protected muscle, and metabolic health you can hold onto.

What This Looks Like at Foundation Wellness

We start with labs, not a prescription pad. Your first visit covers blood sugar, thyroid, hormones, and a history of what you’ve already tried. If semaglutide fits, we map your dose schedule and your weight loss goals together. If it doesn’t fit, we say so and point you somewhere useful.

Our patients ask about realistic results long before they ask about price. The version we hear most at that first visit is some form of “how much of this will I actually keep?” We answer it with the trial ranges above and with your own labs, not with a promise. Our team also puts the check-in cadence and the maintenance plan on paper that same day, so nothing about the next year is a surprise.

Our patients check in monthly, because the difference between 8 percent and 15 percent weight loss usually comes down to who caught the plateau early. According to the Mayo Clinic, these medications are meant to be paired with diet and activity support, which is how we run the program. We serve American Fork and all of Utah, in clinic and by telehealth.

You can see how the program runs on our GLP-1 weight loss in Utah page. Weighing the two main drugs against each other? Start with our semaglutide vs tirzepatide guide. Real pricing sits on the GLP-1 cost in Utah page. The bigger plan lives on our medical weight optimization page.

Key Takeaways

• Adults without diabetes lost 14.9 percent of body weight on semaglutide 2.4 mg over 68 weeks in STEP 1, near 34 pounds on average.
• Adults with type 2 diabetes averaged closer to 10 percent, and a 1 mg dose produced about 7 percent.
• A 15 percent loss is 27 pounds at a 180 pound start and 45 pounds at 300 pounds.
• Loss builds gradually as your dose steps up every four weeks toward the 2.4 mg maintenance dose.
• Stopping brings weight regain for most patients, so plan maintenance before you finish.
• Protein, strength training, and physical activity protect muscle and your long term weight loss results.
• Foundation Wellness serves American Fork and all of Utah, in clinic and by telehealth.

Sources

• New England Journal of Medicine (STEP 1 trial) - nejm.org
• U.S. Food and Drug Administration (FDA) - fda.gov
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - niddk.nih.gov
• Mayo Clinic - mayoclinic.org